C6 NBD Galactosylceramide
| Catalog Number | BL-M000401 |
| CAS Number | 170212-26-7 |
| Description | C6 NBD galactosylceramide is a galactosylceramide derivative that is tagged with a fluorescent group C6 nitrobenzoxadiazole (C6 NBD). C6 NBD galactosylceramide has been used to study intracellular localization and metabolism of galactosylceramide, which is a marker of Krabbe disease. |
 | |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanamide |
| Synonyms | N-hexanoyl-NBD-Galactosylceramide; N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide |
| Molecular Weight | 737.9 |
| Molecular Formula | C36H59N5O11 |
| Purity | ≥98% |
| Density | 1.27±0.1 g/cm3(Predicted) |
| Appearance | Solid Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 58.60%, H 8.06%, N 9.49%, O 23.85% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCNC2=CC=C(C3=NON=C23)[N+](=O)[O-] |
| InChI | InChI=1S/C36H59N5O11/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-28(43)26(24-50-36-35(47)34(46)33(45)29(23-42)51-36)38-30(44)19-16-14-17-22-37-25-20-21-27(41(48)49)32-31(25)39-52-40-32/h15,18,20-21,26,28-29,33-37,42-43,45-47H,2-14,16-17,19,22-24H2,1H3,(H,38,44)/b18-15+/t26-,28+,29+,33-,34-,35+,36+/m0/s1 |
| InChI Key | ZYEQNDHFYIPTAY-LFUFHFQKSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry